Guardant Health Inc. UnitedHealth Policy Coverage Decision on GH Shield Test

Guardant Health (GH) received a positive coverage decision from UnitedHealth for its Shield colorectal cancer screening test, expanding access to 40 million additional Americans.

Key Takeaways

• 1.UnitedHealth issued a positive coverage decision for Guardant Health's Shield test, set to take effect in August 2026.
• 2.Improved commercial payer coverage is expected to unlock significant revenue growth and volume in the 45-64 age demographic.

Table of Contents

• Disclosure Appendix
• Reg AC
• GS Factor Profile
• M&A Rank
• Quantum
• Disclosures
• Company-specific regulatory disclosures
• Distribution of ratings/investment banking relationships
• Price target and rating history chart(s)
• Target price history table(s)
• Regulatory disclosures
• Global product; distributing entities
• General disclosures

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial